Skip Page Header

Home > Guidelines for the screening, care and treatment of persons with hepatitis C infection.

World Health Organization. (2016) Guidelines for the screening, care and treatment of persons with hepatitis C infection. Geneva: World Health Organization. 124 p.

[img]
Preview
PDF (WHO Guidelines for hepatitis C 2016)
802kB
[img]
Preview
PDF (Policy brief 2016: New recommendations in the updated WHO Hepatitis C guidelines) - Supplemental Material
198kB

The objectives of these WHO guidelines are to provide updated evidence-based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV genotype and clinical history, and assess the appropriateness of continued use of certain medicines. This document also includes existing recommendations on screening for HCV infection and care of persons infected with HCV that were first issued in 2014. The key audience for these guidelines are policy-makers in low- and middle-income countries who formulate country-specific treatment guidelines and who plan infectious disease treatment programmes and services, in addition to those people responsible for delivering treatment. The guidelines are appropriate for all countries, including high-income countries.


Item Type
Evidence resource
Publication Type
Guideline
Drug Type
Alcohol or other drugs in general, Opioid
Intervention Type
AOD disorder harm reduction, Screening
Date
April 2016
Pages
124 p.
Publisher
World Health Organization
Corporate Creators
World Health Organization
Place of Publication
Geneva
EndNote
Accession Number
HRB (Electronic Only)
Related URLs

Repository Staff Only: item control page